FIGURE 4 Decrease of the Intracellular ROS Level by GPX4 Activator We also tested whether GPX4 activator would be effective at reducing cytosolic ROS
Research in earlier phases or small trials include evaluation of GLP-1s for cystic fibrosis-related diabetes, polycystic ovarian syndrome (PCOS), chronic obstructive pulmonary disease (COPD), Prader-Willi syndrome (PWS), asthma, substance or alcohol use disorder, and as add-on to insulin for type 1 diabetes (T1DM)
A separate 12-week eye cream study in 41 women showed GHK-Cu outperforming both placebo and vitamin K cream for reducing lines and wrinkles around the eyes while increasing skin density
Antibody generation has been more often seen with twice-daily exenatide and once-daily lixisenatide, presumably influencing their glycaemic effectiveness
Vitam Horm 106:1944 Brinch FA, Dssing H, Nguyen N, Bonnema SJ, Hegeds L, Godballe C, Sorensen JR (2019) The impact of esophageal compression on goiter symptoms before and after thyroid surgery